Sciatica Clinical Trial
Official title:
The Effect of Early MSAT Treatment on Sciatica Caused by Traffic Accidents : A Pragmatic Randomized Controlled Pilot Clinical Trial
The investigators would like to conduct a pilot study prior to a practical randomized control study on the effectiveness of initial MSAT treatment on inpatients complaining of radiating pain and abnormal sensation in the lower extremities caused by traffic accidents.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | December 31, 2024 |
Est. primary completion date | December 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 19 Years to 69 Years |
Eligibility | Inclusion Criteria: 1. a person who has no problem in language communication 2. men and women between the ages of 19 and 69 3. a patient hospitalized for treatment in a car accident 4. A person who complains of radiating pain or abnormal sensation in the lower extremities within three days after a traffic accident 5. A person with a lower extremity radiating pain or abnormal sensation of NRS (Numeric Rating Scale) 5 or higher 6. A person who voluntarily agrees to participate in clinical trials and signs a consent form Exclusion Criteria: 1. Patient diagnosed with certain serious diseases that may cause radiation pain: malignant tumors, spinal fractures, spinal infections, inflammatory spondylitis, etc 2. Patient with progressive neurological deficits or severe neurological symptoms such as Mami syndrome 3. Patient who has undergone surgery, procedures, or is scheduled to undergo surgery on the lumbar spine or lower extremities within the last 3 weeks 4. Patient with other chronic conditions that may interfere with interpretation of treatment effects or results: cardiovascular disease, kidney disease, active hepatitis, diabetic neuropathy, dementia, severe mental illness, epilepsy, etc 5. Patient who may be inadequate or unsafe with acupuncture treatment: hemorrhagic disease, people on anticoagulant therapy, people with severe cardiovascular disease, pregnancy, and infection Severe diabetic patients, seizure disorders, etc. that are concerned 6. Patient currently taking steroids, immunosuppressants, mental illness medications or other medications that may affect research results 7. Patient Participating in clinical trials other than observational studies without therapeutic intervention 8. Patient who has difficulty filling out consent forms to participate in research 9. Patient deemed difficult to conduct this clinical study when judged by the research director |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Jaseng Hospital of Korean Medicine | Seoul | Gangnam-Gu |
Lead Sponsor | Collaborator |
---|---|
Jaseng Medical Foundation |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Numeric Rating Scale of sciatica(NRS of sciatica) | The degree of radiation pain or abnormal sensation in the patient is evaluated through a numerical pain scale. The numerical pain scale is an index expressed by objectifying the degree of subjective pain into numbers for patients over 12 years of age who can communicate and understand the concept of numbers. The patient's pain level is quantified by zero pain and ten pain that cannot be tolerated as death, and is mild (1-4 points), moderate (5-6 points), and severe (7-10 points). | visit 1 (Admission 1 day), visit 2 (Hospital day 2), visit 3(Hospital day 3), visit 4 (Hospital day 4), visit 5 (Hospital day 5), visit 6 (Discharge 1 day), visit 7 (13 day after admission) | |
Secondary | NRS of Lower back pain(NRS of LBP) | In addition to radiation pain and abnormal sensation, the degree of additional low back pain is evaluated together on a numerical pain scale. Write the degree of pain of the patient by stating that the state without pain at all is 0, and the pain that cannot be tolerated as if dying is 10. | visit 1 (Admission 1 day), visit 2 (Hospital day 2), visit 3(Hospital day 3), visit 4 (Hospital day 4), visit 5 (Hospital day 5), visit 6 (Discharge 1 day), visit 7 (13 day after admission) | |
Secondary | Oswestry disability index(ODI) | It is a questionnaire that measures the discomfort patients feel in their daily lives due to back pain, radiating pain in the lower extremities, and abnormal sensations. It is a functional evaluation tool that measures the availability of 10 daily activity. | visit 1 (Admission 1 day), visit 2 (Hospital day 2), visit 3(Hospital day 3), visit 4 (Hospital day 4), visit 5 (Hospital day 5), visit 6 (Discharge 1 day), visit 7 (13 day after admission) | |
Secondary | European Quality of Life-5 Dimensions(EQ-5D) | EQ-5D is one of the most widely used tools in the health care sector to measure health-related quality of life (HRQOL). It is a questionnaire that evaluates the current HRQOL by dividing it into five categories: mobility (M), self-care (SC), user activity (UA), pain/disability (PD), and anxiety/depression (AD). Each item is evaluated in Phase 1 (no problem at all), Phase 2 (slight problem), Phase 3 (moderate problem), Phase 4 (severe problem), and Phase 5 (severe problem).
The EQ-5D Index is an index that calculates health status as a quantitative single value by assigning quality weights to each of the five items of EQ-5D. In this study, quality weights for Koreans at the Korea Centers for Disease Control and Prevention are used and calculated as in the formula below. EQ-5D Index = = 1 - (0.05 + 0.096 × M2 + 0.418 × M3 + 0.046 × SC2 + 0.136 × SC3 + 0.051 × UA2 + 0.208 × UA3 + 0.037 × PD2 + 0.151 × PD3 + 0.043 × AD2 + 0.158 × AD3 + 0.050 × N3) |
visit 1 (Admission 1 day), visit 2 (Hospital day 2), visit 3(Hospital day 3), visit 4 (Hospital day 4), visit 5 (Hospital day 5), visit 6 (Discharge 1 day), visit 7 (13 day after admission) | |
Secondary | Patient Global Impression of Change(PGIC) | PGIC is an index that subjectively evaluates the degree of improvement after treatment by patients. The subjective criteria for improvement and deterioration are ambiguous, so it is usually used as a tool to evaluate treatment satisfaction. The criteria can be checked by analyzing changes in pain and dysfunction indicators for patients who are satisfied with treatment. | visit 1 (Admission 1 day), visit 2 (Hospital day 2), visit 3(Hospital day 3), visit 4 (Hospital day 4), visit 5 (Hospital day 5), visit 6 (Discharge 1 day), visit 7 (13 day after admission) | |
Secondary | Straight Leg Raise Test(SLRT) | It is a physical test performed on patients complaining of urticaria and radial pain and is performed in an supine position. The examiner holds the patient's heel with one hand, holds the patient's knee with the other hand, and raises his leg to bend the hip joint while fixing it so that the patient's knee does not bend. Check the angle at which the patient feels uncomfortable with back pain or radiating pain.
If the knee muscle is a problem when the lower extremity is upright, it is simply related to the back of the thigh, and if the lower extremity radiating pain appears along with nerve driving, it is considered positive. If there is a space-occupying disease such as intervertebral disc hernia, it may indicate back pain or radial pain on the affected side during the tendon examination. Since it is a method of reproducing the patient's pain, the tendon leg is performed first and then the affected leg is examined. |
visit 1 (Admission 1 day), visit 2 (Hospital day 2), visit 3(Hospital day 3), visit 4 (Hospital day 4), visit 5 (Hospital day 5), visit 6 (Discharge 1 day), visit 7 (13 day after admission) | |
Secondary | Lumbar Range of motion(Lumbar ROM) | Measure the active range of lumbar flexion, extension, lateral flexion, and rotation. Evaluate whether there is a limitation in the range of motion due to the patient's back pain and radiating pain. | visit 1 (Admission 1 day), visit 2 (Hospital day 2), visit 3(Hospital day 3), visit 4 (Hospital day 4), visit 5 (Hospital day 5), visit 6 (Discharge 1 day), visit 7 (13 day after admission) | |
Secondary | Adverse event(AE) | It refers to undesirable and unintended objective symptoms, subjective symptoms, or diseases that appear after the procedure during the clinical trial process. It is not necessary to have a causal relationship with the procedure. During the study period, it is collected through patient symptom reports and researcher observations, and the causal relationship between the types of adverse reactions and treatment interventions is written on the EMR. Follow-up observation is conducted when an adverse reaction occurs, and if a serious level of adverse reaction is found, report it quickly. | visit 1 (Admission 1 day), visit 2 (Hospital day 2), visit 3(Hospital day 3), visit 4 (Hospital day 4), visit 5 (Hospital day 5), visit 6 (Discharge 1 day), visit 7 (13 day after admission) | |
Secondary | Severity of L-spine HIVD(Herniated intervertebral disc) or lumbar stenosis on MRI | Data is collected retrospectively through EMR records for research patients who took L-SPINE MRI. The degree of escape and stenosis of the intervertebral disc on MRI is divided into mild, subtle, moderate, and severe. The stage of intervertebral disc escape is divided into bulding, protusion, extrusion, and sequencing, and the direction of escape is classified into central, subarticular, formal, lateral, and interior. Stenosis will be classified as central, lateral repair, and formal. L-spine MRI is evaluated through retrospective chart review during the study period regardless of the patient's admission and discharge. | through study completion, an average of 1 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02384928 -
Effects of Shinbaro Pharmacopuncture in Sciatic Pain Patients With Lumbar Disc Herniation
|
N/A | |
Completed |
NCT05626140 -
COMPARISON OF EFFICACY OF DIFFERENT DRUG COMBINATIONS IN ACUTE SCIATICA
|
Phase 3 | |
Withdrawn |
NCT02313350 -
Intradiscal Discogel® in Resistant Sciatica
|
N/A | |
Unknown status |
NCT02512081 -
"The Lived Experience of Investigations for Sciatica"
|
N/A | |
Terminated |
NCT02951377 -
Mechanical Diagnosis and Treatment and/or Steroid Injections for Lumbar Radiculopathy
|
Phase 1 | |
Completed |
NCT03347929 -
NSAIDs in Sciatica NSAIDS IN SCIATICA
|
Phase 4 | |
Completed |
NCT04145310 -
BOL-DP-o-04 in Patients With Low Back Pain and Sciatica
|
Phase 1/Phase 2 | |
Enrolling by invitation |
NCT04660656 -
Predictive Value of the Five-repetition Sit-to-stand Test After Lumbar Spine surgerySTS-3 Study.
|
||
Completed |
NCT02644421 -
Clinical Trial to Evaluate the Safety and Analgesic Efficacy of VVZ-149 in Lumbar Radiculopathy (Sciatica)
|
Phase 1 | |
Completed |
NCT00991172 -
A Study to Evaluate the Safety and Efficacy of Subcutaneously Administered REGN475(SAR164877) in Patients With Sciatic Pain
|
Phase 2 | |
Completed |
NCT00668434 -
Effectiveness of Oral Prednisone in Improving Physical Functioning and Decreasing Pain in People With Sciatica
|
Phase 2 | |
Completed |
NCT00749996 -
Herniectomy Versus Herniectomy With a Spinal Stabilization System for the Treatment of Complex Disc Disease
|
Phase 4 | |
Completed |
NCT00246948 -
The Efficacy of Active Conservative Treatment for Patients With Severe Sciatica. A Randomized Clinical Controlled Trial
|
N/A | |
Completed |
NCT04155450 -
Effects of Extension Biased External Limb Loading in Addition to McKenzie Extension Protocol in Lumbar Derangement Syndrome
|
N/A | |
Completed |
NCT02284542 -
NAPS: Non-awake Versus Awake Placement of Spinal Cord Stimulators
|
||
Recruiting |
NCT02770963 -
Efficacy of Acupuncture for Discogenic Sciatica
|
N/A | |
Completed |
NCT00364572 -
Efficacy of Epidural Etanercept in the Treatment of Sciatica
|
Phase 1/Phase 2 | |
Completed |
NCT00470509 -
Adalimumab in Severe and Acute Sciatica
|
Phase 2 | |
Active, not recruiting |
NCT03887962 -
Virtual Environment Rehabilitation for Patients With Motor Neglect Trial
|
N/A | |
Completed |
NCT05959317 -
Effects of Pilates Exercises and Neural Dynamic Mobilization in Sciatica Patients
|
N/A |